Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 3Weight Loss 2Prostatic Neoplasms 2Obesity 2Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Diabetes Mellitus 1

Interventions

Exercise 10Diet 6Caloric Restriction 5Metformin 4Octreotide 3Nutrition Assessment 3Cognitive Behavioral Therapy 3anamorelin 2Standard of Care 2Olanzapine 2Mirtazapine 2Melatonin 2Liraglutide 2Eicosapentaenoic Acid 2Diet, Carbohydrate-Restricted 2Diet Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1lime 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1Urine Specimen Collection 1Tirzepatide 1TOPS 1Surveys and Questionnaires 1Sugars 1Sampling Studies 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Weight Loss × Diet, Carbohydrate-Restricted × Clear all
NCT03679260 2023-03-30

Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Cedars-Sinai Medical Center

Phase 2 Completed
22 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed
82 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡